[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide

C104H116F8Ir4N16Si2-8 — CID 157437389

IUPAC[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide
SMILESCC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)C(F)(F)C(F)(F)F.CC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)C(F)(F)F.CC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)[Si](C)(C)C.CC[Si](CC)(CC)C(C)(C)C(C)(C)c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C29H38N4Si.C26H32N4Si.C25H23F5N4.C24H23F3N4.4Ir/c1-8-34(9-2,10-3)29(6,7)28(4,5)25-21-30-26-27(31-25)33(24-19-15-12-16-20-24)22-32(26)23-17-13-11-14-18-23;1-25(2,26(3,4)31(5,6)7)22-18-27-23-24(28-22)30(21-16-12-9-13-17-21)19-29(23)20-14-10-8-11-15-20;1-22(2,23(3,4)24(26,27)25(28,29)30)19-15-31-20-21(32-19)34(18-13-9-6-10-14-18)16-33(20)17-11-7-5-8-12-17;1-22(2,23(3,4)24(25,26)27)19-15-28-20-21(29-19)31(18-13-9-6-10-14-18)16-30(20)17-11-7-5-8-12-17;;;;/h11-19,21-22H,8-10H2,1-7H3;8-16,18-19H,1-7H3;5-13,15-16H,1-4H3;5-13,15-16H,1-4H3;;;;/q4*-2;;;;
InChIKeySSUBPSZZRBZXCU-UHFFFAOYSA-N
MW2567.21 g/mol
LogP29.06
Rot. Bonds22

About [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide

[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide (PubChem CID 157437389) has the molecular formula C104H116F8Ir4N16Si2-8 and a molecular weight of 2567.21 g/mol. Its IUPAC name is [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide.

Molecular Properties

Compound Name[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide
PubChem CID157437389
Molecular FormulaC104H116F8Ir4N16Si2-8
Molecular Weight2567.21 g/mol
Exact Mass2568.75
IUPAC Name[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide
SMILESCC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)C(F)(F)C(F)(F)F.CC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)C(F)(F)F.CC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)[Si](C)(C)C.CC[Si](CC)(CC)C(C)(C)C(C)(C)c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1.[Ir].[Ir].[Ir].[Ir]
InChIInChI=1S/C29H38N4Si.C26H32N4Si.C25H23F5N4.C24H23F3N4.4Ir/c1-8-34(9-2,10-3)29(6,7)28(4,5)25-21-30-26-27(31-25)33(24-19-15-12-16-20-24)22-32(26)23-17-13-11-14-18-23;1-25(2,26(3,4)31(5,6)7)22-18-27-23-24(28-22)30(21-16-12-9-13-17-21)19-29(23)20-14-10-8-11-15-20;1-22(2,23(3,4)24(26,27)25(28,29)30)19-15-31-20-21(32-19)34(18-13-9-6-10-14-18)16-33(20)17-11-7-5-8-12-17;1-22(2,23(3,4)24(25,26)27)19-15-28-20-21(29-19)31(18-13-9-6-10-14-18)16-30(20)17-11-7-5-8-12-17;;;;/h11-19,21-22H,8-10H2,1-7H3;8-16,18-19H,1-7H3;5-13,15-16H,1-4H3;5-13,15-16H,1-4H3;;;;/q4*-2;;;;
InChIKeySSUBPSZZRBZXCU-UHFFFAOYSA-N
XLogP29.06
TPSA129.04 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds22
Heavy Atoms134
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002567.21
LogP ≤ 529.06
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Perfluorinated_chain', 'substructure': 'N/A'}

Analyze [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide?
The IUPAC name of [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide (CID 157437389) is [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide.
What is the SMILES notation for [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide?
The canonical SMILES for [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide is CC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)C(F)(F)C(F)(F)F.CC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)C(F)(F)F.CC(C)(c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1)C(C)(C)[Si](C)(C)C.CC[Si](CC)(CC)C(C)(C)C(C)(C)c1cnc2c(n1)N(c1[c-]cccc1)[CH-]N2c1ccccc1.[Ir].[Ir].[Ir].[Ir].
What is the InChIKey of [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide?
The InChIKey is SSUBPSZZRBZXCU-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H38N4Si.C26H32N4Si.C25H23F5N4.C24H23F3N4.4Ir/c1-8-34(9-2,10-3)29(6,7)28(4,5)25-21-30-26-27(31-25)33(24-19-15-12-16-20-24)22-32(26)23-17-13-11-14-18-23;1-25(2,26(3,4)31(5,6)7)22-18-27-23-24(28-22)30(21-16-12-9-13-17-21)19-29(23)20-14-10-8-11-15-20;1-22(2,23(3,4)24(26,27)25(28,29)30)19-15-31-20-21(32-19)34(18-13-9-6-10-14-18)16-33(20)17-11-7-5-8-12-17;1-22(2,23(3,4)24(25,26)27)19-15-28-20-21(29-19)31(18-13-9-6-10-14-18)16-30(20)17-11-7-5-8-12-17;;;;/h11-19,21-22H,8-10H2,1-7H3;8-16,18-19H,1-7H3;5-13,15-16H,1-4H3;5-13,15-16H,1-4H3;;;;/q4*-2;;;;.
What are the key properties of [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide?
[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide has a molecular weight of 2567.21 g/mol, XLogP of 29.06, 22 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-triethylsilane;[2,3-dimethyl-3-(1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-id-5-yl)butan-2-yl]-trimethylsilane;tetrakis(iridium);5-(4,4,5,5,5-pentafluoro-2,3,3-trimethylpentan-2-yl)-1-phenyl-3-phenyl-2H-imidazo[4,5-b]pyrazin-2-ide;1-phenyl-3-phenyl-5-(4,4,4-trifluoro-2,3,3-trimethylbutan-2-yl)-2H-imidazo[4,5-b]pyrazin-2-ide is sourced from PubChem (CID 157437389), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).